Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening
- Wednesday, October 2, 2019, 7:36
- PR Newswire
- Add a comment
NEW YORK, Oct. 2, 2019 /PRNewswire/ — Xylyx Bio, a pioneer in tissue-specific extracellular matrix biomaterials, today announced the development of substrates for anti-fibrotic drug discovery as the next stage of its pipeline of pre-clinical cell culture products. Through the development…
About the Author
admin has written 20652 stories on this site.